Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease

Table 3

Serum lipid analysis of the rat models.

Group	n	TC (μg/L)	TG (μg/L)	HDL (μg/L)	LDL (μg/L)
NORMAL	10	1.254 ± 0.054	1.029 ± 0.090	1.223 ± 0.057	0.390 ± 0.062
HFD	10	1.693 ± 0.052^#	1.415 ± 0.074^#	0.772 ± 0.650^#	0.751 ± 0.065^#
HFD + MLGZG^L	10	1.463 ± 0.033	1.307 ± 0.042	0.883 ± 0.082	0.647 ± 0.052
HFD + MLGZG^M	10	1.340 ± 0.033	1.234 ± 0.060	0.937 ± 0.061	0.589 ± 0.061
HFD + MLGZG^H	10	1.253 ± 0.041	1.163 ± 0.072	1.105 ± 0.052	0.487 ± 0.050

Note. Data are expressed as the mean ± SD. TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol. HFD: high-fat diet; MLGZG^L: MLGZG low dose; MLGZG^M: MLGZG moderate dose; MLGZG^H: MLGZG high dose. # indicates , HFD group compared to normal control group; indicates , MLGZG-treated groups compared to HFD group.